Auteur: interactie

全球重症监护后营养研究合作平台（GRIP）在第19届中华医学会重症医学年会（CSCCM2025）期间，召开了首届中国分会会议。GRIP副主席范赞滕教授与中国重症医学领域的著名专家——陈德昌、李为群、安有中、柯路、高林教授——进行了深入会谈，推动在重症监护后营养与康复领域的合作研究。

合作计划包括开展全国多中心前瞻性观察性研究（第一阶段），主要关注ICU出院后患者的长期预后，包括生活质量和功能恢复。随后将开展第二阶段“营养促进策略”，探索在中国饮食文化背景下延长标准营养支持（如延长至5天）的可行性。该项目预计将于2025年底启动，共纳入2×125例患者。

此外，正在进行的ABLE临床试验已在研究每日两次口服营养补充剂（ONS）在ICU出院后连续三个月的疗效。该系列研究由南京的柯路教授牵头，得到了ICU营养网络和胰腺炎网络的支持。

范赞滕教授表示：“这次合作体现了GRIP的使命，即为重症监护后的营养护理提供全球化、循证的解决方案。与中国同行的携手合作是改善ICU康复者长期预后的重要一步。”

The Global Research Initiative on Post-ICU Nutrition (GRIP) strengthened its international collaboration with the first Chinese GRIP meeting, held during the 19th Congress of the Chinese Society of Critical Care Medicine (CSCCM2025). GRIP Vice-chair Prof. Arthur van Zanten met with leading Chinese intensivists – Professors Chen Dechang, Li Weiqin, An Youzhong, Ke Lu, and Gao Lin – to advance joint research on nutrition and recovery after intensive care.

Plans include a nationwide multicentre observational study (Phase 1) to investigate long-term outcomes such as quality of life and functional recovery in post-ICU patients. This will be followed by Phase 2, the Nutrition Promotion Strategy, which aims to optimise practical nutritional support in the Chinese context, with the first patient recruitment expected in late 2025 (2×125 patients).

In addition, the ongoing ABLE trial is examining the effect of daily oral nutritional supplements (ONS) for three months after ICU discharge. Coordinated by Prof. Ke Lu in Nanjing, these initiatives are supported by the ICU Nutrition Network and the Pancreatitis Network.
“This collaboration reflects GRIP’s mission to deliver global, evidence-based solutions for post-ICU nutrition,” said Prof. van Zanten. “Working together with our Chinese colleagues is an important step towards improving recovery and long-term outcomes for ICU survivors worldwide.”

The Global Research Initiative on Post-ICU Nutrition (GRIP) officially commenced its work with a landmark start meeting at Hotel Dukes’ Palace in Bruges, Belgium. Chaired by Prof. Dr. Elisabeth De Waele (Brussels, Belgium) and Vice-chaired by Prof. Dr. Arthur van Zanten (Ede-Wageningen, the Netherlands), this gathering brought together leading experts in intensive care, nutrition, rehabilitation, and implementation science from across the globe.

GRIP was founded to address one of the most pressing gaps in critical care: the nutritional management of patients after intensive care. Every year, millions of patients survive prolonged ICU stays, yet many face malnutrition, delayed recovery, and long-term complications. Despite its impact, the post-ICU phase, from the first ICU discharge up to one year, remains under-researched and poorly supported worldwide.

With its vision to ensure that every critically ill patient receives personalised, timely, and effective nutritional care throughout recovery, GRIP is set to advance research, education, and implementation. Its mission is to bridge evidence gaps, develop practical solutions, and empower both patients and healthcare professionals to optimise recovery through better nutrition.
The Bruges meeting marked the beginning of an ambitious global agenda. Participants defined research priorities across ten domains.
Outcomes of the meeting include the preparation of a consensus definition of the post-ICU patient, the design of collaborative research protocols, and plans for a scoping review and position paper to be presented at upcoming international congresses, including ESPEN 2025 in Prague and ISICEM 2026 in Brussels.
This first meeting has been made possible with the support of Nutricia-Danone.

About GRIP

The Global Research Initiative on Post-ICU Nutrition (GRIP) is an international collaborative platform dedicated to improving outcomes for patients recovering from critical illness through evidence-based, personalised nutrition. By fostering research, clinical innovation, and education, GRIP aims to ensure that patients worldwide receive the right nutrition, at the right time, in the right way.

Press Release

Bruges, Belgium – 22–23 March 2025